WOMAC Meaningful Within-patient Change: Results From 3 Studies of Tanezumab in Patients With Moderate-to-severe Osteoarthritis of the Hip or Knee.

Philip Gerard ConaghanRobert H DworkinThomas J Schnitzer Francis BerenbaumAndrew G BushmakinJoseph Christopher Cappelleri Lars Viktrup Lucy Abraham

Published in: The Journal of rheumatology (2022)

These results establish MWPCs for WOMAC domains, at the individual patient level, for patients with moderate-to-severe OA of the hip or knee. [ClinicalTrials.gov: NCT02697773, NCT02709486, and NCT02528188].

Keyphrases

knee osteoarthritis
total knee arthroplasty
case report
high intensity
early onset
rheumatoid arthritis
anterior cruciate ligament